Bashaer Gheyath
Bashaer Gheyath has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Aldo L. Schenone
Division of Cardiology, Montefiore Health System/Albert Einstein College of Medicine, Bronx, NY, USA
2 shared publications Kevin Chen
Internal Medicine Department, Cleveland Clinic, 9500 Euclid Ave, OH, 44195, USA
2 shared publicationsNyal Borges
Cardiovascular Medicine Department, Cleveland Clinic, 9500 Euclid Ave, OH, 44195, USA
2 shared publicationsVenu Menon
Cardiovascular Medicine Department, Cleveland Clinic, 9500 Euclid Ave, OH, 44195, USA
2 shared publicationsAbdur Rahman Khan
Department of Cardiovascular Medicine, University of Louisville, Louisville, Kentucky
1 shared publicationAbhijit Duggal
Pulmonary and Critical Care Medicine Department, Cleveland Clinic – 9500 Euclid Ave OH, 44195, USA
1 shared publication
Latest Publications
- 4 May 2026
- Published by Wiley in Echocardiography
- Vol. 43 (5) , e70489
“Old Tools, New Questions: What Calibrated Integrated Backscatter Reveals About Subclinical Cardiac Remodeling in AAS Users”
Calibrated integrated backscatter (ciB) is revisited as a potential echocardiographic marker of subclinical myocardial remodeling in anabolic-androgenic steroid users. This commentary highlights its ability to bridge myocardial structure and tissue characterization, while addressing current limitations in standardization and clinical applicability.
- 4 May 2026
- Published by Wiley in Echocardiography
- Vol. 43 (5) , e70489
“Old Tools, New Questions: What Calibrated Integrated Backscatter Reveals About Subclinical Cardiac Remodeling in AAS Users”
Calibrated integrated backscatter (ciB) is revisited as a potential echocardiographic marker of subclinical myocardial remodeling in anabolic-androgenic steroid users. This commentary highlights its ability to bridge myocardial structure and tissue characterization, while addressing current limitations in standardization and clinical applicability.
- Open Access
- 26 June 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (13) , 3714
Chemotherapy Related Cardiotoxicity Evaluation—A Contemporary Review with a Focus on Cardiac Imaging
The long-term survivorship of patients diagnosed with cancer has improved due to accelerated detection and rapidly evolving cancer treatment strategies. As such, the evaluation and management of cancer therapy related complications has become increasingly important, including cardiovascular complications. These have been captured under the umbrella term “cardiotoxicity” and include left ventricular dysfunction and heart failure, acute coronary syndromes, valvular abnormalities, pericardial disease, arrhythmia, myocarditis, and vascular complications. These complications add to the burden of cardiovascular disease (CVD) or are risk factors patients with cancer treatment are presenting with. Of note, both pre- and newly developing CVD is of prognostic significance, not only from a cardiovascular perspective but also overall, potentially impacting the level of cancer therapy that is possible. Currently, there are varying recommendations and practices regarding CVD risk assessment and mitigating strategies throughout the cancer continuum. This article provides an overview on this topic, in particular, the role of cardiac imaging in the care of the patient with cancer. Furthermore, it summarizes the current evidence on the spectrum, prevention, and management of chemotherapy-related adverse cardiac effects.
- 26 June 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (13) , 3714
Open AccessChemotherapy Related Cardiotoxicity Evaluation—A Contemporary Review with a Focus on Cardiac Imaging
The long-term survivorship of patients diagnosed with cancer has improved due to accelerated detection and rapidly evolving cancer treatment strategies. As such, the evaluation and management of cancer therapy related complications has become increasingly important, including cardiovascular complications. These have been captured under the umbrella term “cardiotoxicity” and include left ventricular dysfunction and heart failure, acute coronary syndromes, valvular abnormalities, pericardial disease, arrhythmia, myocarditis, and vascular complications. These complications add to the burden of cardiovascular disease (CVD) or are risk factors patients with cancer treatment are presenting with. Of note, both pre- and newly developing CVD is of prognostic significance, not only from a cardiovascular perspective but also overall, potentially impacting the level of cancer therapy that is possible. Currently, there are varying recommendations and practices regarding CVD risk assessment and mitigating strategies throughout the cancer continuum. This article provides an overview on this topic, in particular, the role of cardiac imaging in the care of the patient with cancer. Furthermore, it summarizes the current evidence on the spectrum, prevention, and management of chemotherapy-related adverse cardiac effects.
- Open Access
- 18 October 2022
- Published by Elsevier in Heart Rhythm O2
- Vol. 4 (1) , 18-23
Exploratory use of intraprocedural transesophageal echocardiography to guide implantation of the leadless pacemaker
- 18 October 2022
- Published by Elsevier in Heart Rhythm O2
- Vol. 4 (1) , 18-23
Open AccessExploratory use of intraprocedural transesophageal echocardiography to guide implantation of the leadless pacemaker
- 1 September 2019
- Published by Elsevier in Resuscitation
- Vol. 142, 1-7
Impact of hypothermia on cardiac performance during targeted temperature management after cardiac arrest
- 1 September 2019
- Published by Elsevier in Resuscitation
- Vol. 142, 1-7
Impact of hypothermia on cardiac performance during targeted temperature management after cardiac arrest
- 24 January 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 123 (8) , 1255-1261
Invasive Hemodynamics and Outcomes in Cardiac Arrest Survivors Undergoing Targeted Temperature Management
- 24 January 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 123 (8) , 1255-1261
Invasive Hemodynamics and Outcomes in Cardiac Arrest Survivors Undergoing Targeted Temperature Management
- 1 September 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 120 (5) , 774-781
Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance
- 1 September 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 120 (5) , 774-781
Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance
- Open Access
- 1 January 2017
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 8 (12) , 396-399
Norepinephrine Type Pheochromocytoma With Concomitant Aortic Aneurysms: A Distinctive Association
- 1 January 2017
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 8 (12) , 396-399
Open AccessNorepinephrine Type Pheochromocytoma With Concomitant Aortic Aneurysms: A Distinctive Association